Cormorant Asset Management LLC 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-08 4:06 pm Purchase | 2025-12-04 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Cormorant Asset Management LLC | 8,265,000 9.980% | 8,265,000 (New Position) | Filing |